The global ambulatory cardiac monitoring devices market size accounted for USD 7.65 billion in 2024, grew to USD 8.51 billion in 2025 and is projected to surpass around USD 22.31 billion by 2034, representing a healthy CAGR of 11.30% between 2024 and 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ambulatory Cardiac Monitoring Devices Market
5.1. COVID-19 Landscape: Ambulatory Cardiac Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ambulatory Cardiac Monitoring Devices Market, By Device Type
8.1. Ambulatory Cardiac Monitoring Devices Market Revenue and Volume, by Device Type, 2024-2034
8.1.1. ECG Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Holter Monitors
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Event Monitors
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Implantable Loop recorders
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Mobile Cardiac Telemetry
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Ambulatory Cardiac Monitoring Devices Market, By End-use
9.1. Ambulatory Cardiac Monitoring Devices Market Revenue and Volume, by End-use, 2024-2034
9.1.1. Ambulatory Care Centers
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Hospitals & Clinics
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Ambulatory Cardiac Monitoring Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Device Type (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End-use (2021-2034)
Chapter 11. Company Profiles
11.1. Koninklijke Philips N.V
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Hill-rom Services, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ZOLL Medical Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. NIHON KOHDEN CORPORATION
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. FUKUDA DENSHI
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. iRhythm Technologies Inc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Biotronik SE & Co. KG
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. General Electric Company
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Abbott
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample